Soledad Ravetti

425 total citations
20 papers, 250 citations indexed

About

Soledad Ravetti is a scholar working on Infectious Diseases, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Soledad Ravetti has authored 20 papers receiving a total of 250 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 6 papers in Molecular Biology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Soledad Ravetti's work include HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (4 papers) and Research on Leishmaniasis Studies (4 papers). Soledad Ravetti is often cited by papers focused on HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (4 papers) and Research on Leishmaniasis Studies (4 papers). Soledad Ravetti collaborates with scholars based in Argentina, Colombia and Spain. Soledad Ravetti's co-authors include Daniel A. Allemandi, Santiago D. Palma, Margarita C. Briñón, Santiago Daniel Palma, Sara M. Robledo, Gabriela Turk, Mario A. Quevedo, Sol R. Martínez, Lucía V. Cavallaro and Rodolfo Campos and has published in prestigious journals such as SHILAP Revista de lepidopterología, Bioorganic & Medicinal Chemistry and Experimental Eye Research.

In The Last Decade

Soledad Ravetti

18 papers receiving 239 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Soledad Ravetti Argentina 8 52 47 38 36 29 20 250
Mohammed Rafiq India 7 48 0.9× 67 1.4× 13 0.3× 15 0.4× 35 1.2× 10 259
A. Gupta Australia 7 96 1.8× 28 0.6× 33 0.9× 64 1.8× 25 0.9× 16 350
Patrik Scholz Germany 8 30 0.6× 44 0.9× 64 1.7× 45 1.3× 69 2.4× 11 316
Lucas Amaral-Machado Brazil 13 79 1.5× 16 0.3× 24 0.6× 19 0.5× 53 1.8× 25 385
Débora Fretes Argenta Brazil 13 88 1.7× 43 0.9× 18 0.5× 36 1.0× 67 2.3× 25 435
Shuqin Cui China 10 108 2.1× 70 1.5× 10 0.3× 22 0.6× 67 2.3× 14 337
Fazil Ahmad Saudi Arabia 9 62 1.2× 20 0.4× 12 0.3× 23 0.6× 38 1.3× 26 298
Khizar Abbas Pakistan 13 112 2.2× 14 0.3× 23 0.6× 26 0.7× 77 2.7× 46 418
Doaa A. Helal Egypt 11 69 1.3× 27 0.6× 11 0.3× 28 0.8× 42 1.4× 21 366
Sanjeevani Deshkar India 10 61 1.2× 19 0.4× 15 0.4× 19 0.5× 33 1.1× 42 335

Countries citing papers authored by Soledad Ravetti

Since Specialization
Citations

This map shows the geographic impact of Soledad Ravetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soledad Ravetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soledad Ravetti more than expected).

Fields of papers citing papers by Soledad Ravetti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Soledad Ravetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soledad Ravetti. The network helps show where Soledad Ravetti may publish in the future.

Co-authorship network of co-authors of Soledad Ravetti

This figure shows the co-authorship network connecting the top 25 collaborators of Soledad Ravetti. A scholar is included among the top collaborators of Soledad Ravetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Soledad Ravetti. Soledad Ravetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ravetti, Soledad, et al.. (2025). Preformulation studies and in vitro cytotoxicity of naringin. Drug Development and Industrial Pharmacy. 51(4). 344–353. 1 indexed citations
2.
Guido, Mario E., Rocío Herrero‐Vanrell, José D. Luna, et al.. (2024). Evidence of the protective role of Carvacrol in a retinal degeneration animal model. Experimental Eye Research. 244. 109938–109938.
3.
Murillo, Javier, et al.. (2024). Piperine, quercetin, and curcumin identified as promising natural products for topical treatment of cutaneous leishmaniasis. Parasitology Research. 123(4). 185–185. 4 indexed citations
4.
Ravetti, Soledad, et al.. (2024). Microencapsulation techniques for developing cannabidiol formulations: a review. Therapeutic Delivery. 16(2). 183–197.
5.
Ravetti, Soledad, et al.. (2023). Naringin: Nanotechnological Strategies for Potential Pharmaceutical Applications. Pharmaceutics. 15(3). 863–863. 35 indexed citations
6.
Granero, Gladys E., et al.. (2023). Preformulation Studies of Novel Menthol Prodrugs with Antiparasitic Activity: Chemical Stability, In Silico, and In Vitro Permeability Assays. SHILAP Revista de lepidopterología. 2(3). 770–780. 5 indexed citations
7.
Ravetti, Soledad, et al.. (2023). Enhancing the Functional Properties of Tea Tree Oil: In Vitro Antimicrobial Activity and Microencapsulation Strategy. Pharmaceutics. 15(10). 2489–2489. 5 indexed citations
8.
Robledo, Sara M., et al.. (2022). Menthol carbonates as potent antiparasitic agents: synthesis and in vitro studies along with computer-aided approaches. BMC Complementary Medicine and Therapies. 22(1). 156–156. 8 indexed citations
9.
Ravetti, Soledad, et al.. (2021). Synthesis, In Vitro Antiprotozoal Activity and Cytotoxicity of New Thymol Carbonate Derivatives. ChemistrySelect. 6(25). 6597–6600. 5 indexed citations
10.
Freiberger, María Inés, et al.. (2021). Anin silicoanalysis of Ibuprofen enantiomers in high concentrations of sodium chloride with SARS-CoV-2 main protease. Journal of Biomolecular Structure and Dynamics. 40(12). 5653–5664. 4 indexed citations
11.
Upegui, Yulieth, et al.. (2021). Eugenol carbonate activity against Plasmodium falciparum, Leishmania braziliensis, and Trypanosoma cruzi. Archiv der Pharmazie. 355(3). e2100432–e2100432. 6 indexed citations
12.
Ravetti, Soledad, et al.. (2020). Anti-echinococcal activity of menthol and a novel prodrug, menthol-pentanol, against Echinococcus multilocularis. Acta Tropica. 205. 105411–105411. 11 indexed citations
13.
Ravetti, Soledad, et al.. (2020). Optimization of Microparticle Coating Parameters with Cell Wall of Saccharomyces cerevisiae by Fractional Factorial Design. Journal of Pharmaceutical Innovation. 16(4). 603–619. 2 indexed citations
14.
Ravetti, Soledad, et al.. (2019). Ascorbic Acid in Skin Health. Cosmetics. 6(4). 58–58. 109 indexed citations
15.
Ravetti, Soledad, et al.. (2014). Biological evaluation and molecular modelling of didanosine derivatives. MedChemComm. 5(5). 622–631. 1 indexed citations
16.
Ravetti, Soledad, et al.. (2013). Preformulation studies of novel 5′-O-carbonates of lamivudine with biological activity: solubility and stability assays. Drug Development and Industrial Pharmacy. 40(9). 1246–1252. 8 indexed citations
17.
Ravetti, Soledad, et al.. (2010). Antiviral activity of 5′-O-carbonate-2′,3′-dideoxy-3′-thiacytidine prodrugs against hepatitis B virus in HepG2 2.2.15 cells. International Journal of Antimicrobial Agents. 36(6). 566–569. 6 indexed citations
18.
Ravetti, Soledad, et al.. (2009). Synthesis and anti-HIV activity of novel 2′,3′-dideoxy-3′-thiacytidine prodrugs. Bioorganic & Medicinal Chemistry. 17(17). 6407–6413. 14 indexed citations
19.
Ravetti, Soledad, et al.. (2008). Lipophilicity of 5′‐Carbonates of Lamivudine with Antiretroviral Activity. Correlation Between Different Methods. Journal of Liquid Chromatography & Related Technologies. 31(7). 1014–1032. 14 indexed citations
20.
Quevedo, Mario A., et al.. (2002). LIPOPHILIC CHARACTER OF NOVEL AMINO ACID DERIVATIVES OF ZIDOVUDINE WITH ANTI HIV ACTIVITY. Journal of Liquid Chromatography & Related Technologies. 25(9). 1345–1365. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohammed Rafiq Breakdown of academic impact, for papers by A. Gupta Breakdown of academic impact, for papers by Patrik Scholz Breakdown of academic impact, for papers by Lucas Amaral-Machado Breakdown of academic impact, for papers by Débora Fretes Argenta Breakdown of academic impact, for papers by Shuqin Cui Breakdown of academic impact, for papers by Fazil Ahmad Breakdown of academic impact, for papers by Khizar Abbas Breakdown of academic impact, for papers by Doaa A. Helal Breakdown of academic impact, for papers by Sanjeevani Deshkar
Rankless by CCL
2026